Terms ending in 2037
Every in-force patent on Nestec S.A.'s record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,758,560 | Methods for Treating Sarcopenia and Frailty In force · High confidence | Société des Produits Nestlé S.A. | In force | High confidence | |
| US 10,702,835 | Appliance for Foaming Beverage or Foodstuff In force · High confidence | Société des Produits Nestlé S.A. | In force | High confidence | |
| US 10,609,945 | Compositions Comprising 2FL and LNNT to Control Food Intake and Growth in Infants or Young Children In force · High confidence | Société des Produits Nestlé S.A. | In force | High confidence | |
| US 10,751,308 | Composition for Preventing or Reducing Transepidermal Water Loss In force · High confidence | Société des Produits Nestlé S.A. | In force | High confidence | |
| US 11,083,742 | Human Milk Oligosaccharides for Health Benefits by Prevention of Premature Adiposity Rebound In force · High confidence | Société des Produits Nestlé S.A. | In force | High confidence | |
| US 11,096,410 | Composition for Use in the Prevention And/Or Treatment of Skin Conditions and Skin Diseases In force · High confidence | Société des Produits Nestlé S.A. | In force | High confidence | |
| US 11,224,651 | Compositions Comprising Human Milk Oligosaccharides for Use in Infants or Young Children to Prevent or Treat Allergies In force · High confidence | Société des Produits Nestlé S.A. | In force | High confidence | |
| US 11,229,231 | Human Milk Oligosaccharides Against Later in Life Excessive Fat Mass Accumulation and Related Health Disorders In force · High confidence | Société des Produits Nestlé S.A. | In force | High confidence | |
| US 11,253,530 | Synergistic Production of Butyrate Associated with the Complexity of Hmos Blend for Use in Infants or Young Children for Health Purposes In force · High confidence | Société des Produits Nestlé S.A. | In force | High confidence | |
| US 10,820,616 | Infant Formula System with Adaptive Levels of Human Milk Oligosaccharides (HMOs) In force · High confidence | Société des Produits Nestlé S.A. | In force | High confidence | |
| 83 more term ends in 2037 · Pro | |||||
10 of 93 patents shown. Soonest term end first, then patent number.
Pro members see all 93.
7 of these are in force and held by Nestec S.A..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.